Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis

INTRODUCTION: There is argument over the benefits and risks of drugs for treating chronic musculoskeletal pain. This study compared the efficacy, safety, and tolerability of diclofenac, ibuprofen, naproxen, celecoxib, and etoricoxib for patients with pain caused by osteoarthritis (OA) or rheumatoid...

Descripción completa

Detalles Bibliográficos
Autores principales: van Walsem, Anneloes, Pandhi, Shaloo, Nixon, Richard M, Guyot, Patricia, Karabis, Andreas, Moore, R Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411793/
https://www.ncbi.nlm.nih.gov/pubmed/25879879
http://dx.doi.org/10.1186/s13075-015-0554-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411793/
https://www.ncbi.nlm.nih.gov/pubmed/25879879
http://dx.doi.org/10.1186/s13075-015-0554-0

Ejemplares similares